ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members. Disclaimer ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||
Sodium Oxybate for FibromyalgiaSunday 19 July 2009 About.com's Adrienne Dellwo reports on promising research involving sodium oxybate for Fibromyalgia: NEWSBRIEF: Jazz Pharmaceuticals says data from Phase III trials on JZP-6 (sodium oxybate) show the drug can ease pain, fatigue and sleep disturbance in people with fibromyalgia. Sodium oxybate is the active ingredient in the narcolepsy drug Xyrem. It's already widely used, off label, as a fibromyalgia treatment. It's a controlled substance, however, and requires close monitoring by your doctor. Jazz says side effects were mild to moderate and included headache, nausea, dizziness, vomiting, diarrhea, anxiety and sinusitis. The company has completed a second Phase III trial and expects to announce results within the next few months. If results continue to be positive, Jazz expects to file a New Drug Application with the FDA by the end of 2009. If approved, the drug could conceivably come on the market sometime in 2010 or 2011. • Learn More About JZP-6 Sodium Oxybate This article originally appeared here. You can find out more sodium oxybate at RxList and at Drugs.com.
blog comments powered by Disqus |
||||||||||||
|
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)